207_Combined course Presentations

First page Table of contents Previous page 995 Next page Last page

Cisplatin/Pemetrexed: a valuable option for Stage IIIB/IV NON-squamous NSCLC

OS

OS

FAVORS Gemcitabine

FAVORS Pemetrexed

Scagliotti GV. et al. JCO 2008;26

Made with